ISRAEL AT WAR - DAY 226

Sponsored The Times of Israel - Promoted Content Sheba Global

Sponsored

First in the world: Sheba & NIH developing a pan corona vaccine

Sheba Global

Join us in this captivating video for the SPRI seminar, as we delve into the remarkable journey of Sheba’s Infection Prevention and Control Unit, led by Prof. Regev-Yochay

Amongst the first in the world: Sheba and National Institutes of Health (NIH) are developing a pan corona vaccine to combat future global outbreaks. Join us in this captivating video for the SPRI seminar, as we delve into the remarkable journey of Sheba’s Infection Prevention and Control Unit, led by Prof. Regev-Yochay. This dedicated team recruited over 9,000 healthcare workers to conduct long-term studies during the COVID-19 pandemic.

This groundbreaking collaboration between Sheba, the Vaccine Research Center, Walter Reed Army Institute of Research, and Sanofi aims to create a vaccine covering a range of coronaviruses. The seminar highlights achievements, scientific findings, and future pandemic preparations, addressing concerns like emerging variants and the needs of the immunosuppressed population. Tune in to hear insights from SPRI leadership, Prof. Gili Regev-Yochay, and Dr. Daniel Douek, SPRI Senior Scientific Advisor of the NIH, as we pave the way for a resilient future in global health.

For more information about Sheba Medical Center, visit www.sheba-global.com

Sign in or Register
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Register
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.